Riskpilot← Back to searchSign inGet full accessDedalus Healthcare Denmark ApS
APSActiveCVR 41744901Tangen 27, 1. thComputer programming activities · NACE 6210Est. 202054 employees
Revenue 2024
DKK 90M
-45% vs 2023
EBITDA margin
-33.2%
-729% vs 2023
Equity ratio
-44.8%
Financial strength
Net profit 2024
DKK -68,5M
-716% vs 2023
| Revenue | DKK 90M | -45% |
| EBITDA | DKK -29,9M | -729% |
| Net profit | DKK -68,5M | -716% |
| Total assets | DKK 127,3M | -31% |
| Equity | DKK -57,1M | -600% |
| Employees | 54 | — |
Legal name
Dedalus Healthcare Denmark ApS
CVR number
41744901
Legal form
Anpartsselskab
NACE code
6210 · Computer programming activities
Founded
8. oktober 2020
Share capital
DKK 52.000
Employees
54 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et medlem af direktionen.
Company purpose
Selskabets formål er at drive informationsteknologisk virksomhed og anden i forbindelse hermed stående virksomhed, idet forretningsområderne særlig består i softwareudvikling, driftsserviceydelser samt konsulent- og generelle serviceydelser, der udspringer af den drevne virksomhed.
Address
Tangen 27, 1. th
Email
info.northeurope@dedalus.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 166.664 | 207.027 | 164.370 | 89.963 |
| Staff expenses | -54.667 | -78.996 | -58.332 | -50.053 |
| EBITDA | 90.039 | -3.025 | 4.755 | -29.895 |
| Depreciation & amort. | -10.825 | -8.863 | -6.020 | -343 |
| EBIT | 79.214 | -11.888 | -1.265 | -30.238 |
| Net financials | -703 | 2.949 | 7.954 | -35.775 |
| Profit before tax | 78.511 | -8.939 | 6.689 | -66.013 |
| Tax | 9.650 | 1.442 | -4.420 | 2.461 |
| Net profit | 68.861 | -10.381 | 11.110 | -68.473 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 144.160 | 213.558 | 184.928 | 127.338 |
| Equity | 80.609 | 309 | 11.418 | -57.055 |
| Long-term debt | 0 | 0 | -3.674 | 0 |
| Short-term debt | 53.423 | 202.431 | 173.089 | 184.355 |
| Total debt | 53.423 | 202.431 | 173.089 | 184.355 |
EBITDA margin
-33.2%
This company
15.8%
Market median
-310% vs market
20212024
Equity ratio
-44.8%
This company
38.2%
Market median
-217% vs market
20212024
Return on equity
-6847341400.0%
This company
18.4%
Market median
-37213812057% vs market
20212024
Net profit margin
-76.1%
This company
8.1%
Market median
-1040% vs market
20212024
Asset turnover
0.71×
This company
1.12×
Market median
-37% vs market
20212024
Debt / equity
3.23×
This company
0.62×
Market median
-421% vs market
20212024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2020-10-08 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (5) | ||
HW Management | Management | 2021 – 2022 |
JP Management | Management | 2022 – 2023 |
WL Management | Management | 2020 – 2021 |
HC Management | Management | 2020 – 2021 |
NA Management | Management | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2025 | |
| Former (2) | ||
| Board of Directors | 2021 – 2025 | |
| Board of Directors | 2021 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Dedalus Healthcare Denmark ApS 
Dedalus Amphi A/SBoard members of Dedalus Healthcare Denmark ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Wieland | Management | 0 companies |
| Jan Peter Gille | Management | 0 companies |
| William Leroy Deckelman, Jr. | Management | 0 companies |
| H C Charles Diao | Management | 0 companies |
| Neil Angelo Manna | Management | 0 companies |
| Andrea Ciceri | Board of Directors | 0 companies |
| Hans Vandewyngaerde | Board of Directors | 0 companies |
| Jakob Uffelmann | Chairman | 0 companies |
| Liborio Luca Mastropaolo | Board of Directors | 0 companies |
| Giovanni Aprile | Board of Directors | 0 companies |